INTRODUCTION:

Mimosa pudica(Linn.) obtained from "mirror" signifies the implied affectability of leaves, and "pudica" signifies being modest, resigning, or contracting.¹ Mimosa imitates the creature's affectability that is affectability to light, gravity, time of day, or like sundew drosera, which responds to creepy-crawly contact². So mimosa is humble Plant, sensitive Plant, shame plant, touch me not, sleeping grass, lajjalu in Ayurveda, namaskari in Sanskrit³. Chui Mui, lajwanti, dozing grass, touchy Plant, humble Plant, timid Plant, contact me not, and numerous different names. The aforementioned elaborate use can be credited to its thigmotactic and semimonastic developments.

The conclusion of leaves and hanging down of petioles happens in light of specific upgrades like light, vibration, wounds, wind, contact, warmth, and cold⁴. Other than its elaborate use, Mimosa pudica(Linn.) is a famous plant among society healers to treat a few sicknesses⁵. Since their remedial significance, they have stayed practically speaking in every conventional arrangement of treatments, including Greco Arab Unani-Tibbs, Ayurveda in India, and Chinese⁶. Mimosa pudica(Linn.) is known and esteemed for its analgesic, anti-inflammatory⁷, hypoglycemic⁸ diureti⁹, astringent¹⁰, antispasmodic¹¹, and blood-purifying activities¹². It has been utilized to treat hypertension, menorrhagia¹³, and leucorrhea¹⁴. Wounds and skin inflammation¹⁵ can be pickled by smearing a glue of the entire plant and foliage, separately¹⁵, anticonvulsant¹⁶, nephrolithiasis¹⁷, and many others.

Herbal portrayal of Mimosa pudica (Linn.)^18,19,20

Kingdom- Plantae

Subkingdom -"Tracheobionta", "Vascular plants"

Superdivision- Spermatophyta

Division-Magnoliophyte

Class- "Magnoliopsida", "Dicotyledons"

Subclass -Rosidae

Order - Fabales

Family-Mimosoideae

Genus-Mimosa L.

Figure 1. Mimosa pudica (Linn.)

1. Characters: -

Synonyms: Sleeping Grass, Sensitive Plant, Bashful Mimosa, Humble Plant, Touch-me-not, Chui Mui, Najuk, Lajawanti, Vashini, Touchshy, Varakranta, Lajjabate, Lajjabati, Lajak^21,22.

Plant: Little woody herbs or low-dispersionsubshrub with furry and thorny twigs, hairs glandular^23,24

Leaf: Bipinnate, Sensitive to touch, Pinnae 1-2 pairs, Leaflets 10-20 pairs, Linear, Glabrous²².

Flowers: Heads small, Peduncle, Globose, Axillary, Pink-purple, Calyx campanulate, Petals crenate towards base²⁵

Pods: 1.5-2.5 cm long, carefullysnappy on the sutures²⁶.

Flowering and Fruiting time: Sept.-March in Indian conditions²⁷.

2. Cultivation:

A plant of the tropics, yet besides naturalized in the subtropics, is found at heights up to "1,300" meters. It develops best in zones where yearly daytime temperatures range 22 - 28°C yet can endure 10 - 32°C. It is biased on ice. It favours meaning annual precipitation in the field "1,000 - 2,000"mm yet persists "900 - 3,000"mm. It prefers a radiant position yet can prevail in the very thick shade. It lasts in many soils, including those that are shallow or poor in supplements^28,29 . The plant is very much adjusted to moist sectors with high breezes prefers a pH in the range of 6 - 7, enduring 5 - 7.5. The plant has gotten naturalized all through the Tropics and a significant part of the subtropics. It has become a bug in woodland estates, cropland, plantations, and field. It is primarily liable to turn into a toxic weed when developing dryland field crops, in rained wetland rice, and estate crops³⁰. Plants can blossom, lasting throughout the year. Plants are a fire peril when dry. Even though they can be perpetual, the plants can likewise finish their life-cycle within 90 days. This plant has a cooperative affiliation with certain dirt microbes, these microbe's edifice knobs on the roots and fixes ecological nitrogen. The emerging plant uses a percentage of this nitrogen though some can likewise be utilized by diverse plants becoming nearby³¹.

3. Chemical Constituents:

Phyto-chemical assets of Mimosa pudica (Linn.) Leaves have exposed the propinquity of terpenoids, glycosides, flavonoids, alkaloids, quinines, phenol, saponin and not many coumarin subsidiaries. The leaves, roots, and stems give positive tests for alkaloids; however, the all-out amount present is little³². The medication is additionally seen as wealthy in tannins, and the all-out tannin content was accounted for to be 10%. Because of the substance properties, distinctive concoction mixes were separated³³.

Mimopudine

Potassium5-O-~D-glucopyranosylgentlsate

Mimosa pudica (Linn.) comprises a non-protein aminoacid, L-mimosine which is vague with leucine from Leucaena glauca^34,35 .The nearness of Crocetin dimethyl ester in the plant was set up. It was uncovered that the seed of the plant contains an adhesive made out of d - xylose and d - glucuronic corrosive that yields 17% of greenish-yellow greasy oil. The sterols and terpenoids are available in the plant. The cerebroside part of the two leaves and chloroplasts contains polyunsaturated fat and a long chain sphingosine base³⁶. The cerebroside division of the two leaves and chloroplasts has a polyunsaturated unsaturated fat and a long chain sphingosine base.³⁷ Two novels C-glycosylflavones were detached from the entire Plant of Mimosa pudica, and their assemblies were resolved as 6,7,3′,4′-tetrahydroxyl-8-C- α-l-rhamnopyranosyl- 1 → 2 -β-d-glucopyranosyl flavone and 5,7,3′,4′-tetrahydroxy-8-C β-d-apiose- 1 → 4 -β-d-glucopyranosyl flavones.³⁸ An apyrase from Mimosa pudica (Linn.) Contains N5, N10-methenyl tetrahydrofolate and is stimulated by light³⁹ . It has been accounted for to contain sitosterol, linoleic corrosive, and oleic corrosive. The root of Mimosa pudica (Linn.) screened for acetylcholinesterase inhibitory activity, and it was found that the roots have acetylcholine esterase inhibitory activity ⁴⁰ . The cerebroside portion of the two leaves and chloroplasts contains polyunsaturated fat and a long chain sphingosine base.^40,41 Two new C-glycosylflavones were disengaged from the entire Plant of Mimosa pudica, and their structures were resolved as 6,7,3′,4′-tetrahydroxyl-8-C- α-l-rhamnopyranosyl- 1 → 2 -β-d-glucopyranosyl flavone and 5,7,3′,4′-tetrahydroxy-8-C β-d-apiose- 1 → 4 -β-d-glucopyranosyl flavones⁴²

4. Pharmacological Effect:

4.1. Antidepressant Activity:

An investigation shows that different portions of fluid leaves concentrate of the Plant Mimosa pudica (Linn.) during 30 days' time frame diminishes the fixed status in the FST and increment the pace of fortification got in the DRL-72s test like standard medication, clomipramine, and desipramine which bolster the counter depressant action of leaves of Mimosa pudica (Linn.) be that as it may, doesn't bolster anxiolytic movement when a guinea pig was tried in the raised in addition in the direction of the labyrinth^43-46.

4.2. Anti-Convulsant Activity:

The nearness of comforting and hostile to the convulsantprogram recommends the GABAergic impact of the decoction of the Mimosa pudica (Linn.) leaves. It acts by the portion conditionally while examining pentylenetetrazolinitiate "seizure". However, it was not identified with the picrotoxin site of the GABA receptors as it had no impact on picrotoxin actuated seizures. The hindrance by Mimosa pudica (Linn.) of strychnine instigates seizure NMDA incited turning behaviour proposition the activity all through life glycine receptor and NMDA receptor separately because of the quality of various dynamic segment connections simultaneously.^47-48

4.3. Effects on wound healing:

The 2% w/w methanolic concentrate of Mimosa pudica (Linn.) bring in rewarded for the wound was found to epithelize quicker, and the pace of wound constriction was higher on days 8, 12, and 16 when contrasted with the benchmark group⁴⁴ . The water-logged quintessence of 2% w/w Mimosa pudica (Linn.) was additionally compelling against the wound. The embodiment located applied topically to the open damage and watched the expansion of cell multiplication and collagen blend at the injury site confirmed by an increment in rigidity. The expanded measure of hydroxyproline content in the scab of the creature bolstered the injury mending process when the beast tried with 2% w/w methanolic and complete watery concentrate of Mimosa pudica (Linn.) root among them, the methanolic separate in the grouping of 2% w/w was demonstrated best then fluid one who finished up. The base of this plant gives off an impression of being influential in the treatment of wound recuperating^17,49,51.

4.4. Antifungal Activity:

The methanolic extract and watery quintessence of Mimosa pudica (Linn.) at the 100, 200, and 500µg were exasperated in contradiction of numerous pathogens Aspergillus disinfects for the contagious counteraction by well diffusion test. The most extreme zone of hindrance was acquired for aspergillus treats at the centralization of 200µg/200ml and indicated its antifungal action^1,11,52,54.

4.5. Glucose related activity:

Mimosa pudica (Linn.) leaves when given orally at the portion of 250mg/kg to the ordinary and glucose stacked mice both demonstrated hyperglycemic effect 130. Oil ether and the ethanolic concentrate of this plant at the portion of 600mg/kg were taken care of two alloxan actuated diabetic rodents for as long as seven days. On the seventh day, ethanolic separate demonstrated a 50% decline in serum glucose level when contrasted with standard creatures rewarded with metformin. Be that as it may, oil ether removal didn't show a vast diminishing serum glucose level as long as seven days. Taking everything into account, the counter diabetic action present in the ethanolic separate was found for this plant because of the nearness of alkaloids, tannins, and flavonoids^55-59.

4.6. Diuretic Activity:

It remained accounted for that the Lipschitz test was utilized aimed at evaluation of the diuretic achievement of oil ether, ethanolic, and fluid concentrates of Mimosa pudica (Linn.) depended on water and sodium discharge in guinea pigs and contrasted with rodents rewarded with a high percentage of urea. The "Lipschitz-esteem" is the remainder between discharge by guinea pigs and discharge by the urea control. The ethanolic and fluid concentrate of the plant was accounted for to be tried for assessment of diuretic movement by utilizing Furosemide 20mg/kg as standard. Among the two concentrates, ethanolic removal was accounted for to create meaningful diuretic action at portions of 100 and 200mg/kg. The concentrate caused an expansion in absolute urine volume and particle convergence of Na+, Cl-, k+.^60-63.

4.7. Antivenom Activity:

It is situated accounted for that around 0.13mg, and 0.17 mg of fluid concentrate of plant Mimosa pudica (Linn.) had the option to restrain lethality fundamentally, phospholipase movement, oedema framing the action, in addition, hemorrhagic action of Russell's snake as well Saw scaled snake⁶⁴ . In oedema shaping action, it was accounted for that the base oedema-framing portion was characterized as a minimal measure of venom which, when infused subcutaneously into mice footpad, brings about 30% oedema inside 60 minutes of venom infusion and 50µl of Mimosa pudica (Linn.) distinct was permeated employing. c course.⁶⁵ In hemorrhagic exploit, it was accounted for that the base hemorrhagic percentage was considered as a negligible degree of acrimony which when infused intradermally into mice brings around hemorrhagic damage of 10mm width in 24 hours through the hemorrhagic exploit was evaluated by amalgamationacrimony – Plant detached, and 0.1ml of the intermingling was infused intradermally into mice.⁶⁶ It was accounted for that phospholipase movement phospholipase A2 action was estimated utilizing a backhanded hemolytic test on agarose–erythrocyte–egg yolk gel plate strategy and the adequacy of Mimosa pudica (Linn.) watery quintessence in assassination the phospholipase exploit was done by mergerunswervingportion of venom µg with the several quantities of plant separate µl and ruminated for 30 minutes at 37°C and balance too interconnected as the percentage mg antibodies/mg venom prepared to lessen by half the breadth of the hemolytic sparkle when distinguished with the wearing originated by venom unaided⁶¹. The fluid quintessence of the underlying foundations of Mimosa pudica (Linn.) is accounted for to percentage tentatively repress the hyaluronidase and protease exercises of Indian snakes ,Naja, Viperarusselii, and Echiscarinatus venom^39,67,69^.

4.8. Effect on CNS:

The open-field test OFT is generally utilized for the proportion of universal locomotor movement and to evaluate nervousness, sorrow⁷⁰. What is more, rehashed presentation or expanded meeting length gives a technique for assessing habituation to the undeniably recognizable chamber condition. It has been recommended that two components impact tension like conduct in the open field. The first is social confinement because of the carnal division from confine mates when playing out the test. The second is the pressure made by the novel test condition by utilizing open field test and gap cross-test it has been accounted for that, several developments of creatures and number of entry from the chamber were fundamentally diminished in portion subordinate way at dosages of 100 mg/kg and 200 mg/kg p.o^71-73.

4.9. Antimicrobial Property:

The methanolic concentrate of Mimosa pudica (Linn.) leaves of 50, 100, and 200µg were tried against two bacterial pathogens: specific Citrobacter divergence and Klebsiella pneumonia, their antimicrobial movement. The excellent dispersion measure was affirmed the antimicrobial action at the given fixation.

The quintessence of the leaves of Mimosa pudica (Linn.) consumes antibacterial impact against Bacillus subtitles, Staphylococcus aureus, Klebsiella pneumonia, Pseudomonas aeruginosa, Escherichia coli and Salmonella typhi through the most exciting undertaking was noted against Pseudomonas aeruginosa^74-82.

4.10. Anthelmintic Activity:

The dissimilar fascination 75, 50, and 25% of unsolidified quintessence of the dried leaves of Mimosa pudica (Linn.) was succeeded orally to the pre wormed quitters mudpack issue was gathered at consist interludes for five workweeks⁷⁶ . The parasitological taxation was done by unswerving smear, sedimentation, and inauguration technique, keeping the emblematic methodology. The egg maggot check has done utilizing the Mc Master egg tallying procedure, which uncovered the plant's anthelmintic impact^20,83.

4.11. Activity against hepatitis B.:

The aquatic concentrates of the plant Mimosa pudica (Linn.) remained tried invitro for consequences for HBsAg, and immunological marker, by utilizing ELISA strategy. Mimosa pudic (Linn.)was found to lessen by over half the amount of HBsAg in the serum. Results from the immunodiffusion strategy propose that Mimosa pudica (Linn.) extricate can communicate with HBsAg and reduced its amount in the Hepatitis B patient's serum in vitro^6,20,84-85.

4.12. Antioxidant Property:

In the quantitative measure, the methanolic concentrate of the dried and ground stems of the Plant Mimosa pudica (Linn.) was the best among the other n-hexane and dichloromethane concentrates. It showed a solid antioxidant action with RC50 estimates of 2.10 X 10-2mg/ml. The compound liable for the counter oxidant movement of the Mimosa pudica (Linn.) remained perceived as a phenolic composite existing in it^86-89.

4.13. Antinephrolithiatic action:

Mimosa pudica (Linn.)The root has been utilized in Ayurveda and other antiquated therapeutic frameworks to treat kidney stones, nephrolithiasis, urolithiasis, and diuretic. Be that there is logical information to help this action^90-92

CONCLUSION:

Among the plants of the family Mimosaceae, the flexible uncultivated species Mimosa pudica (Linn.) has to enamour much consideration due to its serious people's therapeutic uses and pharmaceutical qualities. Mimosa. Pudica Linn has regarded people healers to treat disease, diabetes, snakebite, asthma, irritations, ulcers, fever, and wounds. Stimulant, antinociceptive, mitigating, cancer prevention agent, hepatoprotective, antimicrobial, hypolipidemic, and hypoglycemic exercises of Mimosa Pudica Linn is presently additionally thought to be praiseworthy. An enormous number of studies have been accomplished for its antibody action. A few examinations presumed that the counteragent capability of the plant is because of tannins. Be that as it may, tannins answerable for its antidote movement have still not been disengaged in an unadulterated structure. The disinterestedness of antigenomic phytochemicals could spare lives from Mimosa pudica (Linn.) to create helpful detailing after assessment. The concentrates of different pieces of the plant have displayed huge antidiabetic, calming, and hypolipidemic exercises and antinaphrolithiatic movement showing the nearness of practical auxiliary metabolites. This way, analysts must screen these mixes for the improvement of new and experimental medications.

CONFLICT OF INTEREST:

The authors have no conflicts of interest regarding this investigation.

ACKNOWLEDGEMENT:

The author thanks the department of pharmaceutical science, Mandsaur University, Mandsaur M.P., India, and faculty of pharmaceutical science, Shri Shankaracharya technical campus, Bhilai , C.G, India, for providing the necessary facilities to carry out this work.

REFERENCES:

1. Gandhiraja N, Sriram S, Meenaa V, Srilakshmi JK, Sasikumar C, Rajeswari R. Phytochemical screening and antimicrobial activity of the plant extracts of Mimosa pudica L. against selected microbes. Ethnobotanical leaflets. 2009; 2009(5):8.

2. Roblin G. Mimosa Pudica: A Model for the Study of The Excitability IN PLANTS. Biological Reviews. 1979; 54(2):135-153.doi.org/10.1111/j.1469-185x.1979.tb00870.x.

3. Patel SP. Anti-urolithiatic activity of extracts of plant-mimosa pudica l. In rats (Doctoral dissertation).

4. Ahmad H, Sehgal S, Mishra A, Gupta R. Mimosa pudica L. (Laajvanti): An overview. Pharmacognosy Reviews. 2012; 6(12):115-124.doi.org/10.4103/0973-7847.99945

5. Goli.Venkateshwarlu, Ragya Eslavath, Santhosh. Anasuri, Gutha. Suma, Kasireddy.Swapna, E.Rajeshwari. Mimosa pudica-an Important Medicinal Plant: A Review of Its Folklore Medicine and Traditional Uses. Asian J. Res. Pharm. Sci. 4(3): July-Sept. 2014; Page 151-152.

6. Patwardhan B, Warude D, Pushpangadan P, Bhatt N. Ayurveda and traditional Chinese medicine: a comparative overview. Evidence-based complementary and alternative medicine. 2005 Dec 1; 2(4):465-73.

7. Muhammad G, Hussain MA, Jantan I, Bukhari SNA. Mimosa pudica L., a High-Value Medicinal Plant as a Source of Bioactives for Pharmaceuticals. Comprehensive Reviews in Food Science and Food Safety. 2016; 15(2):303-315.doi.org/10.1111/1541-4337.12184

8. Srinivas TL, Lakshmi SM, Shama SN, Reddy GK, Prasanna KR. Medicinal plants as anti-ulcer agents. Journal of Pharmacognosy and Phytochemistry. 2013; 2(4):91-7.

9. Andallu B, Radhika B. Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root.

10. Huffman MA, Seifu M. Observations on the illness and consumption of a possibly medicinal plant Vernonia amygdalina (Del.), by a wild chimpanzee in the Mahale Mountains National Park, Tanzania. Primates. 1989; 30(1):51-63. doi.org/10.1007/BF02381210

11. Anwar F, Latif S, Ashraf M, Gilani AH. Moringa oleifera: A food plant with multiple medicinal uses. Phytotherapy Research. 2007; 21(1):17-25. doi.org/10.1002/PTR.202310

12. Mohan G, Anand SP, Doss A. Efficacy of aqueous and methanol extracts of Caesalpinia sappan L. and Mimosa pudica L. for their potential antimicrobial activity. South Asian Journal of . Biological Science 2011; 1(2):48-57.

13. Joseph B, George J, Mohan J. Pharmacology and traditional uses of Mimosa pudica. International journal of pharmaceutical sciences and drug research. 2013; 5(2):41-4.

14. Chaudhury S, Singh H, Bharati KA. Quantitative analyses on ethnogynecological remedies used by Lodhas of Paschim Medinipur district, West Bengal, India.

15. Venkateshwarlu Goli, Kanakam Vijay Bhaskar, Sravan Prasad Macharla, Jimmidi.Bhaskar, P. Suvarna Devi, T. Ramchander. Effects of Anti-Inflammatory Activity of Mimosa pudica. Asian J. Pharm. Res. 1(3): July-Sept. 2011; Page 69-71.

16. Sharma J, Gairola S, Sharma YP, Gaur RD. Ethnomedicinal plants used to treat skin diseases by Tharu community of district Udham Singh Nagar, Uttarakhand, India. Journal of Ethnopharmacology. 2014, 2; 158:140-206. doi.org/10.1016/j.jep.2014.10.004

17. Ngo Bum E, Dawack DL, Schmutz M, Rakotonirina A, Rakotonirina SV, Portet C, et al. Anticonvulsant activity of Mimosa pudica decoction. Fitoterapia. 2004; 75 (3):309-14. doi.org/10.1016/j.fitote.2004.01.012

18. Ahmed S, Hasan MM, Mahmood ZA. In vitro urolithiasis models: An evaluation of prophylactic management against kidney stones. Journal of Pharmacognosy and Phytochemistry. 2016; 1; 5(3):28.

19. Swati Paul, Dibyajyoti Saha, Srikanta Chowdhury. Pharmacognostic Studies on Aerial Part of Methanolic Extract of Mimosa Pudica. Asian J. Pharm. Tech. 2(3): July-Sept. 2012; Page 101-103.

20. Azmi L, Singh MK, Akhtar AK. Pharmacological and biological overview on Mimosa pudica (Linn.) International journal of pharmacy & life sciences. 2011 Nov 1; 2(11).

21. Singh K, Kumar A, Langyan N, Ahuja M. Evaluation of Mimosa pudica seed mucilage as sustained-release excipient. AAPS PharmSciTech. 2009; 10(4):1121-7. doi.org/10.1208/s12249-009-9307-1

22. Nikita Saraswat, Pranay Wal, Rashmi Saxena Pal, Ankita Wal, Yogendra Pal, Akanksha Pandey. Pharmacognostic Evaluation and Standardization of the leaves of Mimosa pudica, leaves of Murraya koenigii and root of Asparagus racemosus. Research J. Pharm. and Tech. 2020; 13(12):5743-5748. 10.5958/0974-360X.2020.01000.8

23. Lim TK. Mimosa pudica. In: Lim TK, editor. Edible Medicinal And Non-Medicinal Plants: Volume 7, Flowers. Dordrecht: Springer Netherlands; 2014. p. 821-35.

24. Johnson K, Narasimhan G, Krishnan C. Mimosa pudica Linn-a shyness princess: a review of its plant movement, active constituents, uses and pharmacological activity. Int J Pharm Sci Res. 2014; 1; 5(12):5104. 10.13040/IJPSR.0975-8232.5(12).5104-18

25. Molina M, Contreras CM, Tellez-Alcantara P. Mimosa pudica may possess antidepressant actions in the rat. Phytomedicine. 1999 Nov 1; 6(5):319-23. doi.org/10.1016/S0944-7113(99)80052-XGet

26. Weintraub M. Leaf movements in Mimosa pudica L. The New Phytologist. 1952 Jan 1; 50(3):357-82.

27. Mapala K, Pattabi M. Mimosa pudica flower extract mediated green synthesis of gold nanoparticles. Nano World Journal. 2017 Jul 11; 3(2):44-50. 10.17756/nwj.2017-045

28. Chauhan BS, Johnson DE. Germination, emergence, and dormancy of Mimosa pudica. Weed Biology and Management. 2009; 9(1):38-45. doi.org/10.1111/j.1445-6664.2008.00316.x

29. Bhat DM, Murali KS. Phenology of understorey species of tropical moist forest of Western Ghats region of Uttara Kannada district in South India. Current Science. 2001; 10:799-805.

30. Miléo LJ, Silva JF, Albertino SM, Leite BN, Menezes DS, Santos AF. Phytosociology of weeds in cultivation of two varieties of cassava1. Planta Daninha. 2016; 34:267-76. doi.org/10.1590/S0100-83582016340200008

31. Jennifer Suganthi S., Uma Devi P., Suba Kanmani S. Free Radical Scavenging Potential and HPTLC profile of Mimosa pudica. Research J. Pharm. and Tech. 4(7): July 2011; Page 1090-1094.

32. Souza Filho AP, Alves SM, Figueiredo FJ, Dutra S. Germinação de sementes de plantas daninhas de pastagens cultivadas: Mimosa pudica e Ipomoea asarifolia. Planta Daninha. 2001; 19:23-31. doi.org/10.1590/S0100-83582001000100003

33. Ahmad H, Sehgal S, Mishra A, Gupta R. Mimosa pudica L.(Laajvanti): an overview. Pharmacognosy reviews. 2012; 6(12):115. doi.org/10.4103/0973-7847.99945

34. Yuan K, Lü JL, Yin MW. Chemical constituents of C-glycosylflavones from Mimosa pudica. Yao xue xue bao= Acta pharmaceutica Sinica. 2006; 1; 41(5):435-8.

35. Oogai S, Fukuta M, Watanabe K, Inafuku M, Oku H. Molecular characterization of mimosinase and cystathionine β-lyase in the Mimosoideae subfamily member Mimosa pudica. Journal of plant research. 2019; 132(5):667-80. doi.org/10.1007/s10265-019-01128-4

36. Choudhury MD, Chakrabarti P. Cellular and chloroplast lipid composition of the leaves of Mimosa pudica. Phytochemistry. 1980.1; 19(4):519-23. doi.org/10.1016/0031-9422(80)87006-3

37. Yuan K, Lu JL, Jia A, Zhu JX. Two new C-glycosylflavones from Mimosa pudica. Chinese Chemical Letters. 2007; 1; 18(10):1231-4. doi.org/10.4103/0973-1296.75899

38. Ghosh R, Biswas S, Roy S. An apyrase from Mimosa pudica contains N5, N10‐methenyl tetrahydrofolate and is stimulated by light. European journal of biochemistry. 1998; 15; 258(3):1009-13. doi.org/10.1046/j.1432-1327.1998.2581009.x

39. Vinutha B, Prashanth D, Salma K, Sreeja SL, Pratiti D, Padmaja R, Radhika S, Amit A, Venkateshwarlu K, Deepak M. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. Journal of ethnopharmacology. 2007; 19; 109(2):359-63. doi.org/10.1016/j.jep.2006.06.014

40. Leshem YY. Plant membranes: A biophysical approach to structure, development and senescence. Springer Science & Business Media; 2013 Mar 9.

41. Pande M, Pathak A. Preliminary pharmacognostic evaluations and phytochemical Studies on roots of Mimosa pudica (lajvanti). International Journal of Pharmaceutical Sciences Review and Research.2010; 1(1):50-2.

42. Rajendran R, Krishnakumar E. Hypolipidemic activity of chloroform extract of Mimosa pudica leaves. Avicenna Journal of Medical Biotechnology. 2010; 2(4):215.

43. Eloziia N, Kumar N, Kothiyal P, Deka P, Nayak BK. A review on antidepressant plants. Journal of Pharmacy Research. 2017;11(5):382-96. doi 10.22376/ijpbs/lpr.2020.10.5.L180-185

44. Shaikh Z, Roy SP, Patel P, Gohil K. Medicinal value of Mimosa pudica as an anxiolytic and antidepressant: a comprehensive review. World journal of pharmacy and pharmaceutical sciences. 2016; 13; 5:420-32.

45. Goli V, Bhaskar KV, Macharla SP, Bhaskar J, Devi PS, Ramchander T. Effects of anti-Inflammatory activity of Mimosa pudica.International journal of basic and clinical pharmacy. 2011;1 3 :69-71.

46. Kashmira JG, Mayuri AL, Varsha MS. A comprehensive review on 'Mimosa pudica': A potential herbal panacea. Journal of Biologically Active Products from Nature. 2011;1;1(5-6):285-92. doi.org/10.1080/22311866.2011.10719096

47. Bum EN, Dawack DL, Schmutz M, Rakotonirina A, Rakotonirina SV, Portet C, Jeker A, Olpe HR, Herrling P. Anticonvulsant activity of Mimosa pudica decoction. Fitoterapia. 2004;1;75(3-4):309-14. doi.org/10.1016/j.fitote.2004.01.012

48. Naveen A, Mannala S, Jayasree T, Kumar KV, Nagesh C, Narapogu V. Evaluation of anticonvulsant activity of alcoholic extract of Mimosa pudica in Swiss albino rats. Journal of Chemical and Pharmaceutical Research. 2014;6(4):1175-9.

49. Goli V, Kanakam V, Pavankumar G, Kirankumr P, Harishbabu K, Ravi M. Wound healing activity of Mimosa pudica in albino wistar rats. Journal of Chemical and Pharmaceutical Research. 2011;3(5):56-60.

50. Kokane DD, More RY, Kale MB, Nehete MN, Mehendale PC, Gadgoli CH. Evaluation of wound healing activity of root of Mimosa pudica. Journal of ethnopharmacology. 2009 ;15;124(2):311-5. doi.org/10.1016/j.jep.2009.04.038

51. Kannan S, Aravinth S, Sam E, Kumar J, Saminathan K, Suthakaran R. Wound healing activity of Mimosa pudica Linn formulation. International Journal of PharmTech Research. 2009; 11(4):1554-8.

52. Tamilarasi T, Ananthi T. Phytochemical Analysis and Anti Microbial Activity of Mimosa pudica (Linn.) Research Journal of Chemical Sciences; 2012; 2231:606X.

53. Neela FA, Sonia IA, Shamsi S. Antifungal activity of selected medicinal plant extract on Fusarium oxysporum Schlechtthe causal agent of fusarium wilt disease in tomato. American Journal of Plant Sciences. 2014; 7; 2014. doi.org/10.4236/ajps.2014.518281

54. Digrak M, Alma MH, Ilçim A, Sen S. Antibacterial and antifungal effects of various commercial plant extracts. Pharmaceutical Biology. 1999; 1; 37(3):216-20. doi.org/10.1076/phbi.37.3.216.6307

55. Sutar NG, Sutar UN, Behera BC. Antidiabetic activity of the leaves of Mimosa pudica (Linn.) in albino rats. Journal of herbal medicine and toxicology. 2009; 3(1):123-6.

56. Yupparach P, Konsue A. Hypoglycemic and hypolipidemic activities of ethanolic extract from Mimosa pudica L. in normal and streptozotocin-induced diabetic rats. Pharmacognosy Journal. 2017; 9(6). doi.org/10.5530/pj.2017.6.130

57. Pandey P, Kang S, Maheshwari DJCS. Isolation of endophytic plant growth promoting Burkholderia sp. MSSP from root nodules of Mimosa pudica. Current Science 2005:177-80.

58. Rajendiran D, Kandaswamy S, Sivanesan S, Radhakrishnan S, Gunasekaran K. Potential antidiabetic effect of Mimosa pudica leaves extract in high fat diet and low dose streptozotocin-induced type 2 diabetic rats. International Journal of Biology Research. 2017; 2(4):55-62.

59. Tunna TS, Ahmed QU, Uddin AB, Sarker M, Islam Z. Weeds as alternative useful medicinal source: Mimosa pudica (Linn.) on diabetes mellitus and its complications. In Advanced Materials Research 2014; 995: 49-59). doi.org/10.4028/www.scientific.net/AMR.995.49

60. Rekha Rajendran, S Ruby. Diuretic and Laxative Activities of Methanol Extract of Mimosa pudica Leaves. Research J. Pharm. and Tech. 3(2): April- June 2010; Page 556-558.

61. Ueda M, Yamamura S. Leaf-closing substance of Mimosa pudica L.; chemical studies on another leaf-movement of mimosa II. Tetrahedron Letters. 1999; 9; 40(15):2981-4. doi.org/10.1016/S0040-4039(99)00342-1

62. Baghel A, Rathore DS, Gupta V. Evaluation of diuretic activity of different extracts of Mimosa pudica (Linn.) Pakistan journal of biological sciences. 2013 Oct 1; 16(20):1223-5. doi.org/10.3923/pjbs.2013.1223.1225

63. Sangma TK, Meitei UD, Sanjenbam R, Khumbongmayum S. Diuretic property of aqueous extract of leaves of Mimosa pudica (Linn.) on experimental albino rats. Journal of Natural Products. 2010; 3(2010):172-8.

64. Meenatchisundaram S, Michael A. Preliminary studies on antivenom activity of Mimosa pudica root extracts against Russell's viper and saw scaled viper venom by in vivo and in vitro methods. Pharmacologyonline. 2009; 2:372-4.

65. Sanaye MM, Joglekar CS, Pagare NP. Mimosa-A brief overview. Journal of Pharmacognosy and Phytochemistry. 2015 Jul 1; 4(2). doi.org/10.9734/BJPR/2017/32973

66. Nishijima CM, Rodrigues CM, Silva MA, Lopes-Ferreira M, Vilegas W, Hiruma-Lima CA. Anti-hemorrhagic activity of four Brazilian vegetable species against Bothrops jararaca venom. Molecules. 2009; 14(3):1072-80. doi.org/10.3390/molecules14031072

67. Meenatchisundaram S, Sindhu MK. In Vivo and In Vitro Studies on Neutralizing Effects of Acorus calamus and Withania somnifera root extracts against Echis carinatus venom. Iranian journal of pharmacology and therapeutics (2011): 26-30.

68. Girish K, Mohanakumari HP, Nagaraju S, Vishwanath B, Kemparaju K. Hyaluronidase and protease activities from Indian snake venoms: neutralization by Mimosa pudica root extract. Fitoterapia. 2004; 75 3-4:378-80. doi.org/10.1016/j.fitote.2004.01.006

69. Soares AM, Ticli FK, Marcussi S, Lourenço MV, Januario AH, Sampaio SV, Giglio JR, Lomonte B, Pereira PS. Medicinal plants with inhibitory properties against snake venoms. Current Medicinal Chemistry.1; 12(22):2625-41. doi.org/10.2174/092986705774370655

70. Serova LI, Laukova M, Alaluf LG, Sabban EL. Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress. Behavioural brain research. 2013; 1; 250:139-47. doi.org/10.1016/j.bbr.2013.05.006

71. Sajid I, Bijan K, Zamiul R, Mominul I, Ekramul H. CNS Depressant and Antinociceptive Activities of the Aerial Parts of Mimosa pudica. Indian Journal Pharmaceutical Science; 2013; 5:127-33.

72. Hossain M, Sultana S, Pharmacy. In-vivo Assessment of Neuropharmacological Activity of Methanol Bark Extract of Mimosa pudica in Mice. Advance in Pharmacology and Pharmacy. 2019; 7 2 :33-7.doi.org/10.13189/app.2019.070202

73. Adeyemi OO, Akindele AJ, Yemitan OK, Aigbe FR, Fagbo FI. Anticonvulsant, anxiolytic and sedative activities of the aqueous root extract of Securidaca longepedunculata Fresen. Journal of ethnopharmacology. 2010; 20; 130(2):191-5. doi.org/10.1016/j.jep.2010.04.028

74. Balsaraf SV, Chole RH. Antibacterial efficacy of Mimosa Pudica (Lajavanti) against streptococcus mutans. Journal of Indian Association of Public Health Dentistry. 2014; 1; 12(4):317. doi.org/10.4103/2319-5932.147677

75. Sandeep DS, Narayana Charyulu R, Prashant Nayak, Aliss Maharjan, Indira Ghalan. Formulations of Antimicrobial Polyherbal Hand wash. Research J. Pharm. and Tech. 2016; 9(7):864-866. doi.org/10.5958/0974-360X.2016.00163.3

76. Rajalakshmi. K, N. Banu. Evaluation of Antibacterial Activity of Sodium Copper Chlorophyll in from Mimosa pudica L. Research J. Pharm. and Tech. 2017; 10(2): 487-489. doi.org/10.5958/0974-360X.2017.00097.X

77. Jainey P. James, Sneh Priya, Divya Jyothi. Effect of PLGA polymer on Antimicrobial Activity and the Release Studies of Nanoparticle Hydrogel Containing Mimosa pudica Extract. Research J. Pharm. and Tech 2018; 11(7): 2876-2880. doi.org/10.5958/0974-360X.2018.00530.9

78. Akter A, Neela F, Khan M, Islam M, Alam M. Screening of ethanol, petroleum ether and chloroform extracts of medicinal plants, Lawsonia inermis L. and Mimosa pudica L. for antibacterial activity. Indian journal of pharmaceutical science. 2010; 72 3 :388. doi.org/10.4103/0250-474X.70492

79. Sreenivasulu V, Kumar NS, Suguna M, Asif M, Al-Ghurabi EH, Huang ZX, Zhen Z. Biosynthesis of silver nanoparticles using Mimosa pudica plant root extract: characterization, antibacterial activity and electrochemical detection of dopamine. International journal of electrochemistry and science. 2016 Dec 1; 11:9959-71. doi.org/10.20964/2016.12.69

80. Tomar RS, Shrivastava V, Kaushik S. In vitro efficacy of methanolic extract of Mimosa pudica against selected micro-organisms for its broad spectrum antimicrobial activity. International Journal of Current Microbiology and Applied Sciences. 2014; 3(4):780-4.

81. Md. Omar Faruk, Dibyajyoti Saha, Srikanta Chowdhury, Swati Paul, Md. Golam Kabir. In vitro Antioxidant activity of Methanolic Aerial Part Extract of Mimosa pudica. Research J. Pharmacology and Pharmacodynamics.2012; 4(4): 202-205.

82. Muhammad MT, Abdullahi K, Shehu K, Shinkafi SA. Antifungal activity of Mimosa pudica leaves extracts against fungal isolates from razor bumps in Sokoto Metropolis, Nigeria. Annals of Biological Sciences. 2015; 3(1):16-9.

83. Robinson RD, Williams LA, Lindo JF, Terry SI, Mansingh A. Inactivation of strongyloides stercoralis filariform larvae in vitro by six Jamaican plant extracts and three commercial anthelmintics. The West Indian Medical Journal. 1990; 1; 39(4):213-7.

84. Malayan J, Selvaraj B, Warrier A, Shanmugam S, Mathayan M, Menon T. Anti-mumps virus activity by extracts of Mimosa pudica, a unique Indian medicinal plant. Indian journal of Virology 2013; 24(2):166-73. doi.org/10.1007/s13337-013-0143-2

85. Jaya V, Ibrahim H, Othman L. Activities of Selected Plants against Hepatitis B Immunological Marker HBsAg. Malaysian Journal of Science. 2004; 26; 23(2):127-33.

86. Nazeema T, Brindha V. Antihepatotoxic and antioxidant defense potential of Mimosa pudica. International Journal of drug discovery. 2009; 1:1-4.

87. P. Muthukumaran, P. Shanmuganathan , C. Malathi. In Vitro Antioxidant Evaluation of Mimosa pudica. Asian J. Pharm. Res. 1(2): April-June 2011; Page 44-46.

88. Zhang J, Yuan K, Zhou W-l, Zhou J, Yang P. Studies on the active components and antioxidant activities of the extracts of Mimosa pudica (Linn.) from southern China.Pharmacognosy magazine .2011; 25(7) :35. doi.org/10.15835/nbha48311959

89. Arokiyaraj S, Sripriya N, Bhagya R, Radhika B, Prameela L, Udayaprakash NK. Phytochemical screening, antibacterial and free radical scavenging effects of Artemisia nilagirica, Mimosa pudica and Clerodendrum siphonanthus–An in–vitro study. Asian Pacific Journal of Tropical Biomedicine. 2012;1;2(2):S601-4. doi.org/10.1016/S2221-1691(12)60281-0

90. Ahmed S, Hasan MM, Mahmood ZA. Antiurolithiatic plants of family Fabaceae: A memoir of mechanism of action, therapeutic spectrum, formulations with doses. Journal of Pharmacognosy and Phytochemistry. 2017; 6(3):592-6.

91. Lakshmi T, Devaraj E. Antiurolithiatic activity of phytochemical extracts: A review. Journal of Advanced Pharmacy Education & Research.2017; 7(3).

92. KVSRG P, Sujatha D, Bharathi K. Herbal drugs in urolithiasis-a review. Pharmacog Rev. 2007 Jan; 1(1):175-8.

Received on 06.07.2021 Modified on 17.10.2021

Research J. Pharm. and Tech 2022; 15(9):4293-4299.

DOI: 10.52711/0974-360X.2022.00721